Uptake of clinical genetic testing for ovarian cancer in Ontario: A population-based study

BACKGROUND: Approximately 13% of ovarian cancers in Canada are attributable to a mutation in BRCA1 or BRCA2. In 2001, genetic testing for BRCA1 and BRCA2 became freely available to all women in Ontario with a diagnosis of invasive ovarian cancer. It is unknown what proportion of women with ovarian c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Metcalfe, Kelly A., Fan, Isabel, McLaughlin, John, Risch, Harvey A., Rosen, Barry, Murphy, Joan, Bradley, Linda, Armel, Susan, Sun, Ping, Narod, Steven A.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3074978/
https://ncbi.nlm.nih.gov/pubmed/19019415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2008.10.007
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars